Contract Drug Producer Catalent to Purchase Paragon Bioservices in $1.2 Billion Deal – The Wall Road Journal

0
37
Contract Drug Producer Catalent to Purchase Paragon Bioservices in $1.2 Billion Deal – The Wall Road Journal

Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal

Contract drug producer Catalent Inc. agreed to purchase intently held Paragon Bioservices Inc. for $1.2 billion, in accordance with individuals accustomed to the matter, the newest deal within the rising marketplace for gene-therapy medicine.

The all-cash deal, which is anticipated to be introduced Monday morning, would assist Catalent broaden its gene-therapy manufacturing capabilities, the individuals stated. The transaction is anticipated to shut within the second quarter.

Source

News Comments
0 Shares

Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal
Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal
Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal
Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal
Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal

Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal

Contract Drug Producer Catalent To Purchase Paragon Bioservices In $1.2 Billion Deal - The Wall Road Journal